Clinical trials

  • Clinical trial in Axial spondyloarthritis
  • TULISOKIBART for Ankylosing spondylitis | Radiographic axial spondyloarthritis
  • ZIFTOMENIB for Acute myeloid leukemia | NPM1-mutated acute myeloid leukemia | KMT2A-rearranged acute myeloid leukemia
  • N-(4-FLUOROPHENYL)-N-(4-((7-METHOXY-6-(METHYLCARBAMOYL)QUINOLIN-4- YL)OXY)PHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE for Neuroendocrine tumours | Pancreatic neuroendocrine tumour
  • EP102 for Advanced solid tumours
  • ITEPEKIMAB for Chronic rhinosinusitis with nasal polyps
  • IMMUNOSTEM for Type 1 diabetes mellitus
  • FERRIC CARBOXYMALTOSE for Pulmonary hypertension | Iron deficiency
  • TERIPARATIDE for Osteoporotic vertebral fractures | Osteoporotic hip fracture
  • CANAGLIFLOZIN for Chronic kidney disease stage 5 | Chronic Kidney disease
  • AZD3632 for Acute myeloid leukaemia | Acute lymphoblastic leukaemia | Myelodysplastic syndromes
  • [(2S,5S)-5-{4-AMINO-5-[4-(2,3-DIFLUOROPHENOXY)PHENYL]IMIDAZO[5,1-F][1,2,4]TRIAZIN-7-YL}OXAN-2-YL]METHANOL for Relapsed/refractory chronic lymphocytic leukemia|Relapsed/refractory small lymphocytic lymphoma